Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 83 results for "horlicks and boost"

GSK Consumer to step up focus on new products
Business Standard India

GSK Consumer to step up focus on new products

GlaxoSmithKline Consumer Healthcare, the maker of brands such as Horlicks and Boost, will step up its focus on new products. Voltaren pain reliever and Otrivin nasal drops, which come from the joint venture with Novartis, will be integrated into the ... Smart Investor, 2 days ago

1 images for "horlicks and boost"

Business Standard India, 2 days ago
Livemint.com

GSK Consumer Healthcare Q3 net up 37%

Spending on advertising and promotions for the company that sells Horlicks and Boost stood at Rs. New Delhi: GlaxoSmithKline (GSK) Consumer Healthcare Ltd on Monday reported a 37% rise in standalone net profit for the quarter ended on 31 December. ...
 Livemint.com4 days ago GSK Consumer Healthcare edges up after good Q3 result  Capital Market4 days ago
APN News

SBI Pinkathon Mumbai powered by Women Horlicks 2015 successfully completes its fourth edition run

Previous story: Health Camp by NSSH finds most in Usgaon as anaemic Next story: Mumbai: SBI Pinkathon, empowering Indian Women, an initiative to raise awareness about the importance of a healthy lifestyle for women and issues like breast ...
 APN News1 month ago SBI Pinkathon held  Banking Frontiers2 months ago
American Banking News - Forex

Jefferies Group Equities Analysts Boost Earnings Estimates for GlaxoSmithKline plc (GSK)

GlaxoSmithKline plc (NYSE:GSK) Equities research analysts at Jefferies Group lifted their FY2016 earnings per share estimates for shares of GlaxoSmithKline plc in a research report issued on Thursday, Zacks Investment Research reports. Jefferies ...
 WKRB News3 weeks ago Jefferies Group Brokers Boost Earnings Estimates for GlaxoSmithKline plc (GSK)  American Banking News - Forex3 weeks ago GlaxoSmithKline plc (GSK) Issues Earnings Results, Meets Estimates  American Banking News - Forex1 week ago Jefferies Group Equities Analysts Cut Earnings Estimates for GlaxoSmithKline plc (GSK)  WKRB News4 weeks ago
American Banking News

Stock Yards Bank & Trust Company Boosts Stake in GlaxoSmithKline plc (GSK)

Stock Yards Bank & Trust Company increased its position in GlaxoSmithKline plc (NYSE:GSK) by 0.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned ...
 American Banking News2 weeks ago J. W. Burns & Company Boosts Position in GlaxoSmithKline plc (GSK)  WKRB News3 weeks ago GlaxoSmithKline plc (GSK) Stake Increased by Crow Point Partners  WKRB News1 month ago Catawba Capital Management VA Sells 1,890 Shares of GlaxoSmithKline plc (GSK)  American Banking News - Forex1 week ago
[x]  
American Banking News - Forex

Deutsche Bank Boosts GlaxoSmithKline plc (GSK) Price Target to GBX 1,540

GlaxoSmithKline plc (LON:GSK) had its target price increased by Deutsche Bank from GBX 1,500 ($21.84) to GBX 1,540 ($22.42) in a research note issued to investors on Monday, Marketbeat reports. The brokerage presently has a hold rating on the stock.
 American Banking News - Forex3 weeks ago GlaxoSmithKline plc (GSK) Given New GBX 1,540 Price Target at Deutsche Bank  WKRB News3 weeks ago GlaxoSmithKline plc (GSK) Given a GBX 1,800 Price Target by Goldman Sachs Analysts  American Banking News - Forex1 month ago GlaxoSmithKline plc (GSK) Earns A Credit Rating  American Banking News - Forex1 month ago

Banking Stocks Tumble

Posted by Equitymaster The Sensex fell below the 24,000 mark amid heavy selling activity in banking stocks and weak Asian markets . While the BSE-Sensex closed lower by 262 points, the NSE-Nifty closed lower by 82 points. The S&P BSE Midcap and S&P BSE Small ...
 Equitymaster.com2 days ago

Buy GlaxoSmith Con; target of Rs 6940: Prabhudas Lilladher

Prabhudas Lilladher's research report on GlaxoSmith Con We are increasing FY16 and FY17 EPS estimates by 2.4‐5.7% factoring in benefits of price increase and Novartis OTC business. GSK continues to gain share in MFD segment due to stronghold of ...
 Moneycontrol.com2 days ago
Business Standard India

Double-digit sales growth critical but it has to be sustainable: Manoj Kumar

Manoj Kumar was appointed managing director (MD) of GlaxoSmithKline Consumer Healthcare in May last year. He came at a time when the maker of Horlicks and Boost was seeing top line growth slide to low single digits with consumer sentiment remaining ...
 Smart Investor3 days ago
Business Standard India

GSK Consumer Healthcare to focus on driving consumption

GlaxoSmithKline Consumer Healthcare will focus on driving consumption through targeted communication, innovation, and expansion of distribution of its products, even as the FMCG sector continues to battle macro-economic challenges. Manoj Kumar, ...
 Hindu Business Line3 days ago No cheer on demand front for GSK Consumer  Smart Investor3 days ago GSK Consumer: No cheer on demand front  Smart Investor3 days ago GlaxoSmithkline Consumer Healthcare Ltd. : Consumer Packaged Goods - Company Profile, SWOT & Financial Analysis  MarketResearch.com3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less